Aaliyah Nakamura

DiaMedica Therapeutics Achieves Significant Progress Across Pipeline, Highlights Positive Interim Results for Preeclampsia Program

DMAC

DiaMedica Therapeutics Achieves Significant Progress Across Pipeline, Highlights Positive Interim Results for Preeclampsia Program

DiaMedica Therapeutics recently concluded a productive year across its pipeline, achieving key milestones and delivering promising results. The company's President and Chief Executive Officer, Rick Pauls, highlighted the progress made in 2025 during the fiscal year's earnings conference call. In his opening remarks, Mr. Pauls emphasized

By Aaliyah Nakamura
Cognyte Achieves Double-Digit Revenue Growth in Q4 2026, Exceeds Expectations for Fiscal Year

CGNT

Cognyte Achieves Double-Digit Revenue Growth in Q4 2026, Exceeds Expectations for Fiscal Year

Cognyte, a leading provider of mission-critical intelligence technology, announced strong results in its fourth quarter fiscal year 2026 earnings conference call. The company reported double-digit revenue growth, with gross margin and profitability improving significantly. In his opening remarks, Elad Sharon, CEO of Cognyte, emphasized the importance of the company'

By Aaliyah Nakamura